Zacks Research Has Positive Outlook for VRTX Q1 Earnings
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Equities research analysts at Zacks Research boosted their Q1 2025 earnings estimates for shares of Vertex Pharmaceuticals in a research note issued on Monday, March 3rd. Zacks Research analyst R. Department now forecasts that the pharmaceutical company will post earnings per share of $3.61 for the quarter, […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Equities research analysts at Zacks Research boosted their Q1 2025 earnings estimates for shares of Vertex Pharmaceuticals in a research note issued on Monday, March 3rd. Zacks Research analyst R. Department now forecasts that the pharmaceutical company will post earnings per share of $3.61 for the quarter, […]
